BioCentury | Aug 15, 2020
Deals

Scipher tech could fatten Galapagos’ IBD pipeline

...Phase III testing for two gut inflammation indications.Scipher Medicine Corp. has...
...– Janus kinase-1JAK-3 – Janus kinase-3 Sandi Wong Galapagos N.V. Scipher Medicine Corp. Autoimmune Inflammatory...
BioCentury | Feb 19, 2020
Finance

Feb. 19 Financial Quick Takes: bluebird's delayed BLA timeline, plus fundings for NeoTx, Scipher and EnClear

...has raised more than $60 million to date. Optum Ventures adds to Scipher's series B Scipher Medicine Corp....
...to remove toxic proteins from the CSF. Paul Bonanos, Associate Editor Zynteglo (LentiGlobin BB305 gene therapy) bluebird bio Inc. Scipher Medicine Corp. EnClear...
BioCentury | Jun 6, 2019
Emerging Company Profile

Scipher: decoding drug response from protein interactions

...machine learning-based analyses of patient gene expression data to spotlight pathologically relevant markers. According to Scipher Medicine Corp....
...has filed patent applications covering the algorithms and treatment-related use of the diagnostics. COMPANY PROFILE Scipher Medicine Corp....
...Deaconess Medical Center, Boston, Mass. Brigham and Women's Hospital, Boston, Mass. Northeastern University, Boston, Mass. Scipher Medicine Corp....
Items per page:
1 - 3 of 3
BioCentury | Aug 15, 2020
Deals

Scipher tech could fatten Galapagos’ IBD pipeline

...Phase III testing for two gut inflammation indications.Scipher Medicine Corp. has...
...– Janus kinase-1JAK-3 – Janus kinase-3 Sandi Wong Galapagos N.V. Scipher Medicine Corp. Autoimmune Inflammatory...
BioCentury | Feb 19, 2020
Finance

Feb. 19 Financial Quick Takes: bluebird's delayed BLA timeline, plus fundings for NeoTx, Scipher and EnClear

...has raised more than $60 million to date. Optum Ventures adds to Scipher's series B Scipher Medicine Corp....
...to remove toxic proteins from the CSF. Paul Bonanos, Associate Editor Zynteglo (LentiGlobin BB305 gene therapy) bluebird bio Inc. Scipher Medicine Corp. EnClear...
BioCentury | Jun 6, 2019
Emerging Company Profile

Scipher: decoding drug response from protein interactions

...machine learning-based analyses of patient gene expression data to spotlight pathologically relevant markers. According to Scipher Medicine Corp....
...has filed patent applications covering the algorithms and treatment-related use of the diagnostics. COMPANY PROFILE Scipher Medicine Corp....
...Deaconess Medical Center, Boston, Mass. Brigham and Women's Hospital, Boston, Mass. Northeastern University, Boston, Mass. Scipher Medicine Corp....
Items per page:
1 - 3 of 3